Back to top

Madrigal Pharmaceuticals initiated with an Overweight at Wells Fargo

Wells Fargo initiated coverage of Madrigal Pharmaceuticals (MDGL) with an Overweight rating and $685 price target The firm sees over $7B in peak sa...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Madrigal Pharmaceuticals, Inc. (MDGL)